FirstClub's $55M Series B: India's 'Quality-First' Quick Commerce Bet
Bengaluru's FirstClub raised $55M Series B in June 2026, doubling its valuation to $255M by betting that quality — not just speed — wins quick commerce.
Raising startup funding requires matching your stage, traction, and sector to the right investors. Our startup funding resources cover everything from first checks to growth rounds — with actionable guidance for founders navigating today's market.
Explore startup funding articles to sharpen your raise and find investors who fit your company.
Bengaluru's FirstClub raised $55M Series B in June 2026, doubling its valuation to $255M by betting that quality — not just speed — wins quick commerce.
UK biotech IMU Biosciences extended its oversubscribed Series A past $53M in June 2026 to map and decode the human immune system for drug discovery.
Barcelona biopharma Ona Therapeutics closed an oversubscribed $86.6M Series B in June 2026 to advance first-in-class antibody-drug conjugates for resistant cancers.
UK healthcare-tech company Semble raised a £30M Series C led by Revaia in June 2026, scaling its practice-management platform for clinicians.
Edinburgh legal-AI startup Wordsmith raised a $70M Series B in June 2026, backed by Highland Europe and Index Ventures, reaching $100M in total funding.
New York-based Blue Cloud Ventures announced the final close of Fund V on June 2, 2026, bringing total AUM above $1 billion for enterprise SaaS and AI growth investing.